CTI's European marketing application for pacritinib in certain myelofibrosis patients accepted for review; shares ahead 10% premarket [Seeking Alpha]
CTI BioPharma Corp. (CTIC)
Last cti biopharma corp. earnings: 11/1 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ctibiopharma.com
Company Research
Source: Seeking Alpha
Thinly traded nano cap CTI BioPharma (NASDAQ: CTIC ) perks up premarket on increased volume in response to its announcement that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) seeking approval of pacritinib for the treatment of myelofibrosis patients who have thrombocytopenia (low blood platelets). The review clock by the EMA's Committee for Medicinal Products for Human Use (CHMP) is 210 days, excluding question or opinion response periods. Pacritinib is an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1 and CSF1R. The JAK family of enzymes plays a key role in normal blood cell growth and development, immune responses and the expression of proinflammatory cytokines. Now read: Mylan breast cancer generic approved by FDA panel »
Show less
Read more
Impact Snapshot
Event Time:
CTIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTIC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTIC alerts
High impacting CTI BioPharma Corp. news events
Weekly update
A roundup of the hottest topics